Mortality rate in patients with nosocomial acinetobacter meningitis from a Brazilian hospital

Brazilian Journal of Infectious Diseases

Volumn 14, Issue 5, 2010, Pages 437-440

  Tuon, Felipe Francisco ^a   Penteado Filho, Sergio R ^a   Amarante, Diogo ^a   Andrade, Marcio A ^a   Borba, Luis A ^a  

^a HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

Author keywords

Acinetobacter; Acinetobacter baumannii; Ampicillin sulbactam; Imipenem; Meningitis; Neurosurgery

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ACINETOBACTER; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE DURATION; FEMALE; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MALE; MORTALITY; MULTIDRUG RESISTANCE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT FAILURE;

EID: 78951476419     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702010000500003     Document Type: Article

References (20)

1. Sacar S, Turgut H, Toprak S et al. A retrospective study of central nervous system shunt infections diagnosed in a university hospital during a 4-year period. BMC Infect Dis 2006; 6:43.
2. Erdem I, Hakan T, Ceran N et al. Clinical features, laboratory data, management and the risk factors that affect the mortality in patients with postoperative meningitis. Neurol India 2008; 56:433-7.
3. Streharova A, Benca J, Holeckova K et al. Comparison of postsurgical and community acquired bacterial meningitis - analysis of 372 cases within a nationwide survey. Neuro Endocrinol Lett 2007; 28(Suppl 3):7-9.
4. Huttova M, Freybergh PF, Rudinsky B et al. Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality. Neuro Endocrinol Lett 2007; 28(Suppl 2):15-6.
5. Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother 2007; 60:197-9.
6. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI documento M100-S20. Wayne, PA. Clinical and Laboratory Standards Institute 2010.
7. Rodriguez GA, Blanco A, Asensi V et al. Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments. J Antimicrob Chemother 2008; 61:908-13.
8. Chen SF, Chang WN, Lu CH et al. Adult Acinetobacter meningitis and its comparison with non-Acinetobacter gramnegative bacterial meningitis. Acta Neurol Taiwan 2005; 14:131-7.
9. Falagas ME, Kopterides P, Siempos II. Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 2006; 43:389-90.
10. Levin AS. Treatment of Acinetobacter spp infections. Expert Opin Pharmacother 2003; 4:1289-96.
11. Reis AO, Luz DA, Tognim MC, Sader HS, Gales AC. Polymyxin- resistant Acinetobacter spp. isolates: what is next? Emerg Infect Dis 2003; 9:1025-7.
12. Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007; 29:9-25.
13. Lee CH, Tang YF, Su LH, Chien CC, Liu JW. Antimicrobial effects of varied combinations of meropenem, sulbactam, and colistin on a multidrug-resistant Acinetobacter baumannii isolate that caused meningitis and bacteremia. Microb Drug Resist 2008; 14:233-7.
14. Fulnecky EJ, Wright D, Scheld WM, Kanawati L, Shoham S. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis. J Infect 2005; 51:e249-51.
15. Gleeson T, Petersen K, Mascola J. Successful treatment of Acinetobacter meningitis with meropenem and rifampicin. J Antimicrob Chemother 2005; 56:602-3.
16. Wadi JA, Al Rub MA. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline. Ann Saudi Med 2007; 27:456-8.
17. Kim BN, Peleg AY, Lodise TP et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009; 9:245-55.
18. Gulati S, Kapil A, Das B, Dwivedi SN, Mahapatra AK. Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU. Neurol India 2001; 49:134-7.
19. Chen HP, Lai CH, Chan YJ et al. Clinical signifi cance of Acinetobacter species isolated from cerebrospinal fluid. Scand J Infect Dis 2005; 37:669-75.
20. Rodriguez GA, Maradona JA, Asensi V et al. Postsurgical meningitis caused by Acinetobacter baumannii: study of 22 cases and review of the literature. Rev Clin Esp 2001; 201:497-500.